iFIT Cluster of Excellence Newsletter Vol. I |
|
|
Dear members, With our new Email Newsletter, we want to keep you up to date with all new information surrounding our “Image-Guided and Functionally Instructed Tumor Therapies” Cluster of Excellence. The newsletter will appear periodically.
If you have any comments or feedback feel free to get in touch with us: ifitoffice@med.uni-tuebingen.de With best regards,
iFIT Office Team |
|
|
|
Dr. Clemens Hinterleitner awarded the Silver Medal of the Walter-Siegenthaler Society
|
|
|
| Dr. Judith Feucht receives Curious Mind Award
|
|
|
| iFIT Strategy Retreat & Scientific Advisory Board Meeting at Schluchsee
|
|
|
| Symposium: New Horizons in Precision Medical Imaging & Therapy |
|
|
| New approach developed to predict response of immunotherapies in lung cancer |
|
|
| Excellence Workshop in International S.T.E.M. Communication, Productivity & Career Skills |
|
|
| Prof. Juliane Walz receives International Immunocompromised Host Society (ICHS) Takeda Virology Award |
|
|
| Prof. Rammensee in radio interview with SWR2 on the subject of 4th corona vaccination |
|
|
| iFIT excellence podcast episode "Tackling cancer with T cells" |
|
|
| Jun. Prof. Matthias Gehringer
|
|
|
| Prof. Konstantin Nikolaou
|
|
|
|
Cancer Moonshot℠ Seminar Series with Prof. Rammensee
6th of December 2022 at 04:30pm (CET)
|
|
|
|
iFIT Science & Christmas
9th of December 2022 at 4:30pm
iFIT Building, Röntgenweg 11 |
|
|
| iFIT Seminar Series with Enrico Lugli
23rd of January 2023 at 12:00pm
CRONA HS 210, Hoppe-Seyler-Straße 3
|
|
|
|
iFIT Workshop: Fundamentals of Scientific Writing with Dr. Birgit Hollenbach
23rd to 24th of January 2023 from 09:30am - 3:30pm
iFIT Conference Room, Röntgenweg 11
|
|
|
|
iFIT Seminar Series with Jovana Cupovic
30th of January 2023 at 12:00pm
CRONA HS 210, Hoppe-Seyler-Straße 3
|
|
|
| iFIT Science Speed Dating Event
14th of February 2023 from 10:30am - 12:30pm
Konferenzzentrum Schnarrenberg, Room 1 & 2, Otfried-Müller-Str. 6
|
|
|
|
Excellence in International S.T.E.M. Communication, Productivity & Career Skills with Dr. Paul Charlton
7th of February 2023 from 09:00am - 4:30pm |
|
|
|
iFIT Lunch & Learn Session with Lukas Mager
22nd of February 2023 at 12:00pm
CRONA HS 210, Hoppe-Seyler-Straße 3
|
|
|
| 1st International iFIT Conference in Zell am See (Austria)
21st - 23rd of March 2023 |
|
|
NUT Carcinoma - An Underdiagnosed Malignancy |
Lauer UM, […], Zender L NUT Carcinoma-An Underdiagnosed Malignancy. Front Oncol. 2022 Jul 26;12:914031. PMID: 35957893; PMCID: PMC9360329. 10.3389/fonc.2022.914031 IF: 5.4 |
HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1 |
Schuller S, […], Dauch D, […] Singer S (2022). “HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1.” Cancers (Basel) 14(2). 10.3390/cancers14020459 IF: 6.6 |
Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor |
Serafim, RAM, […], Zender L, […], Laufer SA, […], Gehringer M (2022). “Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor.” J Med Chem 65(4): 3173-3192. 10.1021/acs.jmedchem.1c01165 IF: 7.4 |
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity |
Heitmann JS, […], Nelde A, Maringer Y, […], Richter M, […], Wacker M, […], Löffler MW […], Rammensee HG, Salih HR, Walz JS (2022). “A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity." Nature 601(7894): 617-622. 10.1038/s41586-021-04232-5 IF: 69.5
|
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL
|
Mehta, NK, Pfluegler M, […], Heitmann JS, […], Zekri L, […], Hörner S, […], Jung G, Salih HR (2022). “A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL." J Immunother. Cancer. 10(3):e003882 (2022) 10.1136/jitc-2021-003882 IF: 12.5
|
T cell-mediated additive cytotoxicity – death by multiple bullets |
Weigelin, Bettina, Friedl, Peter (2022). “T cell-mediated additive cytotoxicity – death by multiple bullets." Trends in Cancer, December 2022, Vol. 8, No. 12 10.1016/j.trecan.2022.07.007 IF: 14.2 |
Adenosine A2a receptor antagonism restores additive cytotoxicity by cytotoxic T-cells in metabolically perturbed tumors |
Slaats J, Wagena E, Berends A, Peters E, Bakker GJ, van Erp M, Weigelin B, Adema GJ, Friedl P (2022). “Adenosine A2a receptor antagonism restores additive cytotoxicity by cytotoxic T-cells in metabolically perturbed tumors." Cancer Immunology Research. 2022. 10.1158/2326-6066.CIR-22-0113 IF: 11.2
|
|
|
PhD Student – Hyperpolarized Metabolic Imaging |
DKTK Tübingen - Department of Preclinical Imaging and Radiopharmacy, University Hospital Tübingen (UKT) |
|
|
Follow us on social media
|
Legal Notice
Cluster of Excellence “Image-Guided and Functionally Instructed Tumor Therapies” (iFIT)
Röntgenweg 11
72076 Tübingen, Germany Contact:
Public Relations
Steven Pohl Mail: steven.patrick.pohl@med.uni-tuebingen.de Click here to unsubscribe
|
|
|
|
